Access the full text.
Sign up today, get DeepDyve free for 14 days.
Y. Cossart (2004)
Human Parvovirus B19American Journal of Transplantation, 4
H. Zaaijer, M. Koppelman, C. Farrington (2004)
Parvovirus B19 viraemia in Dutch blood donorsEpidemiology and Infection, 132
C. Engelfriet, H. Reesink (2000)
The Optimal Treatment for Haemophiliacs Who Have Developed Factor VIII or -IX AntibodiesVox Sanguinis, 78
W. Roth, E. Seifried (2002)
The German experience with NATTransfusion Medicine, 12
Young Young, Brown Brown (2004)
Parvovirus B19N Engl J Med, 350
H. Chisaka, E. Morita, N. Yaegashi, K. Sugamura (2003)
Parvovirus B19 and the pathogenesis of anaemiaReviews in Medical Virology, 13
Y. Cossart, B. Cant, A. Field, D. Widdows (1975)
PARVOVIRUS-LIKE PARTICLES IN HUMAN SERAThe Lancet, 305
B. Cohen, A. Field, S. Gudnadóttir, S. Beard, J. Barbara (1990)
Blood donor screening for parvovirus B19.Journal of virological methods, 30 3
E. Manaresi, G. Gallinella, A. Labate, P. Zucchelli, D. Zaccarelli, Simone Ambretti, S. Delbarba, M. Zerbini, M. Musiani (2004)
Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donorsEpidemiology and Infection, 132
K. Hartman, K. Brown, S. Green, N. Young (1994)
LACK OF EVIDENCE FOR PARVOVIRUS B19 VIRAEMIA IN CHILDREN WITH CHRONIC NEUTROPENIABritish Journal of Haematology, 88
H. Kelly, D. Siebert, R. Hammond, J. Leydon, P. Kiely, W. Maskill (2000)
The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the worldEpidemiology and Infection, 124
D. Candotti, K. Danso, Armen Parsyan, A. Dompreh, J. Allain (2006)
Maternal-fetal transmission of human parvovirus B19 genotype 3.The Journal of infectious diseases, 194 5
W. Roth, Marijke Weber, E. Seifried (1999)
Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank settingThe Lancet, 353
Armen Parsyan, S. Kerr, S. Owusu-Ofori, G. Elliott, J. Allain (2006)
Reactivity of Genotype-Specific Recombinant Proteins of Human Erythrovirus B19 with Plasmas from Areas Where Genotype 1 or 3 Is EndemicJournal of Clinical Microbiology, 44
W. Roth, S. Buhr, C. Drosten, E. Seifried (2000)
NAT and viral safety in blood transfusion.Vox sanguinis, 78 Suppl 2
(2000)
NAT SCREENING FOR BLOOD DONORS Volume 47, October 2007 TRANSFUSION
K. Nagai, Teruaki Morohoshi, T. Kudoh, Y. Yoto, N. Suzuki, Y. Matsunaga (1992)
TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOOD WITH MEGAKARYOCYTOPENIA ASSOCIATED WITH HUMAN PARVOVIRUS B19 INFECTIONBritish Journal of Haematology, 80
S. Modrow (2006)
Parvovirus B19: the causative agent of dilated cardiomyopathy or a harmless passenger of the human myocard?Ernst Schering Research Foundation workshop, 55
F., McOMISH, P. Yap, '. Jordan, '. Hart, B. Cohen, P. Simmonds (1993)
Detection of parvovirus B19 in donated blood: a model system for screening by polymerase chain reactionJournal of Clinical Microbiology, 31
K. Muir, E. Fitzsimons (1992)
HUMAN PARVOVIRUS INFECTION AND TRANSIENT ERYTHROBLASTOPENIA OF CHILDHOODBritish Journal of Haematology, 81
M. Anderson, P. Higgins, L. Davis, J. Willman, S. Jones, I. Kidd, J. Pattison, D. Tyrrell (1985)
Experimental parvoviral infection in humans.The Journal of infectious diseases, 152 2
T. Pumarola (1995)
[Parvovirus B19].Medicina clinica, 104 1
K. Shirono, H. Tsuda (1995)
Parvovirus B19‐associated haemophagocytic syndrome in healthy adultsBritish Journal of Haematology, 89
G. Kurtzman, N. Frickhofen, J. Kimball, D. Jenkins, A. Nienhuis, N. Young (1989)
Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy.The New England journal of medicine, 321 8
B. Cohen, M. Buckley (1988)
The prevalence of antibody to human parvovirus B19 in England and Wales.Journal of medical microbiology, 25 2
E. Manaresi, G. Gallinella, S. Venturoli, M. Zerbini, M. Musiani (2004)
Detection of parvovirus B19 IgG: choice of antigens and serological tests.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 29 1
C. Prowse, C. Ludlam, P. Yap (1997)
Human Parvovirus B19 and Blood ProductsVox Sanguinis, 72
Glen Mandahl, G. Gulbransen, E. Cardis, Dr Darby, I. Kawachi, R. Winkelmann, J. Auld (1990)
Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease.British Medical Journal, 300
Larry Anderson, Cecilia, Tsou, A. Robert, Parker, L. Terence, Chorba, Herta Wulff, Peter Tattersall, P. Philip, Mortimer (1986)
Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assayJournal of Clinical Microbiology, 24
Armen Parsyan, Emmanuel Addo-Yobo, S. Owusu-Ofori, Henrietta Akpene, F. Sarkodie, J. Allain (2006)
Effects of transfusion on human erythrovirus B19‐susceptible or ‐infected pediatric recipients in a genotype 3–endemic areaTransfusion, 46
M. Koppelman, H. Cuypers, T. Emrich, H. Zaaijer (2004)
Quantitative real‐time detection of parvovirus B19 DNA in plasmaTransfusion, 44
M. Tsujimura, K. Matsushita, H. Shiraki, H. Sato, K. Okochi, Y. Maeda (1995)
Human Parvovirus B19 Infection in Blood DonorsVox Sanguinis, 69
Martin Enders, A. Weidner, G. Enders (2006)
Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of GermanyEpidemiology and Infection, 135
K. Hokynar, J. Brunstein, M. Söderlund-Venermo, O. Kiviluoto, E. Partio, Y. Konttinen, K. Hedman (2000)
Integrity and full coding sequence of B19 virus DNA persisting in human synovial tissue.The Journal of general virology, 81 Pt 4
E. Heegaard, A. Hornsleth (1995)
Parvovirus: the expanding spectrum of diseaseActa Pædiatrica, 84
BACKGROUND: Although the main transmission pathway of parvovirus B19 (B19) is typically via the respiratory route, several transfusion‐transmitted infections have been reported. To increase blood safety, all blood donations to our blood donor service have been screened by a B19 minipool real‐time nucleic acid testing (NAT) since April 2000. Additional customers have been screened since the summer of 2003. STUDY DESIGN AND METHODS: In total, 2.8 million donations from Germany and Austria were screened for B19 by real‐time minipool NAT. A subgroup of 50 B19 DNA–positive donors was screened for B19 immunoglobulin G (IgG) and IgM antibodies and B19 DNA over a 6‐month period. Results were compared to those of 100 B19 DNA–negative donors. RESULTS: Data accumulated over the past 6 years indicate a high incidence period from May 2004 to January 2006. In total, the incidence was 12.7 and 261.5 per 100,000 donations with high virus loads equal to or above 105 and below 105 IU per mL, respectively. Median virus concentration in the case group was 4.85 × 107 IU per mL at Time Point T0 and was reduced to 4 × 102 IU per mL at the time of the next donation (3 months later). Neutralizing antibodies (VP2) were detected in all donations if virus load was reduced to less than 105 IU per mL. CONCLUSION: The release of B19 DNA–positive blood products with a concentration of less than 105 IU per mL is thought to be safe due to the high level of neutralizing VP2 antibodies and is currently examined in a donor recipient infectivity study. In contrast, blood products with a high B19 DNA concentration (≥105 IU/mL), some of which did not contain neutralizing antibodies, were discarded to protect at risk individuals.
Transfusion – Wiley
Published: Oct 1, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.